Fabian Knorr
Hamburg, HH, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Circulating Tumor DNA in Pediatric Mature B-Cell Non-Hodgkin Lymphoma for Genotyping and Minimal Disease Monitoring.
Journal: Pediatric blood & cancer
Published: October 19, 2024
Variant ALK-fusion positive anaplastic large cell lymphoma (ALCL): A population-based paediatric study of the NHL-BFM study group.
Journal: British journal of haematology
Published: November 02, 2023
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
Diagnosis and management of ALK-positive anaplastic large cell lymphoma in children and adolescents.
Journal: Best practice & research. Clinical haematology
Published: January 22, 2023
Allogeneic haematopoietic cell transplant in patients with relapsed/refractory anaplastic large cell lymphoma-Response.
Journal: British journal of haematology
Published: October 09, 2022
Combination therapy with crizotinib and vinblastine for relapsed or refractory pediatric ALK-positive anaplastic large cell lymphoma.
Journal: Haematologica
Published: August 09, 2022
Quantification of Minimal Disease by Digital PCR in ALK-Positive Anaplastic Large Cell Lymphoma: A Step towards Risk Stratification in International Trials?
Journal: Cancers
Published: March 15, 2022
Characterization of IG-MYC-breakpoints and their application for quantitative minimal disease monitoring in high-risk pediatric Burkitt-lymphoma and -leukemia.
Journal: Leukemia
Published: February 15, 2022
Last Updated: 09/26/2026